117 HR 270 IH: Genetically Engineered Salmon Labeling Act U.S. House of Representatives 2021-01-11 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I117th CONGRESS1st SessionH. R. 270IN THE HOUSE OF REPRESENTATIVESJanuary 11, 2021Mr. Young (for himself, Mr. DeFazio, and Ms. Bonamici) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend the market name of genetically altered salmon in the United States, and for other purposes.

1.

Short title

This Act may be cited as the Genetically Engineered Salmon Labeling Act.

2.

Purposes

It is the purpose of this Act to—(1)ensure that consumers in the United States can make informed decisions when purchasing salmon; and(2)authorize an independent scientific review of—(A)the possible effects of genetically engineered salmon on wild salmon stocks; and(B)the Food and Drug Administration’s approval of genetically engineered salmon for human consumption.

3.

Market name for genetically engineered salmon

(a)

In General

Notwithstanding any other provision of law, for purposes of applying the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), the acceptable market name of any salmon that is genetically engineered shall include the words “Genetically Engineered” or GE prior to the existing acceptable market name.(b)

Definition

For purposes of this section, salmon is genetically engineered if it has been modified by recombinant DNA (rDNA) techniques, including the entire lineage of salmon that contain the rDNA modification.

4.

Third-party review of certain salmon approval

The Secretary of Health and Human Services shall ensure that an independent scientific organization conducts a review of the environmental assessment that was carried out by the Food and Drug Administration in support of an approval of a new animal drug application related to AquAdvantage Salmon, dated November 12, 2015.